Intensity-modulated radiation therapy in gynecologic malignancies

Current Treatment Options in Oncology

Volumn 5, Issue 2, 2004, Pages 97-108

  Salama, Joseph K ^b   Roeske, John C ^b   Mehta, Neil ^b   Mundt, Arno J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; ANTINEOPLASTIC AGENT; CISPLATIN;

BODY REGIONS; COLLIMATOR; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DOSIMETRY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LEUKOPENIA; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; REVIEW; RISK BENEFIT ANALYSIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 3142710861     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-004-0042-2     Document Type: Review

References (45)

1. Cleaves M: Radium: with a preliminary note on radium rays in the treatment of cancer. Med Rec 1903, 64:1719-1723.
2. Corn BW, Lanciano RM, Greven KM, et al.: Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol 1994, 12:510-515.
3. Perez CA, Breaux S, Bedwinek JM, et al.: Radiation therapy alone in the treatment of carcinoma of the uterine cervix II: analysis of complications. Cancer 1984, 54:235-246.
4. Snijders-Keiholz A, Griffioen G, Davelaar J, et al.: Vitamin B12 malabsorption after irradiation for gynaecological tumours. Anticancer Res 1993, 13:1877-1881.
5. Creutzberg CL, van Putten WL, Koper PC, et al.: Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial carcinoma: multicentre randomized trial. Lancet 2000, 355:1404-1411.
6. Keys HM, Bundy BN, Stehman FB, et al.: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999, 340:1154-1161.
7. Lhomme C, Fumoleau P, Fargeot P, et al.: Results of the European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix. J Clin Oncol 1999, 17:3136-3142.
8. Rose PG, Cha SD, Tak WK, et al.: Radiation therapy for surgically proven para-aortic node metastases in endometrial carcinoma. Int J Radiat Oncol Biol Phys 1992, 24:229-235.
9. Gibbons S, Martinez A, Schray M, et al.: Adjuvant whole abdomino-pelvic irradiation for high-risk endometrial carcinoma. Int J Radiat Oncol Biol Phys 1991, 21:1019-1024.
10. Ferreira PR, Braga-Filho A, Barletta A, et al.: Radiation therapy alone in stage III-B cancer of the uterine cervix: a 17-year-old experience in south Brazil. Int J Radiat Oncol Biol Phys 1999, 45:441-446.
11. Stock RG, Chen AS, Flickinger JC, et al.: Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys 1995, 31:31-36.
12. Leibel SA, Fuks Z, Zelefsky MJ, et al.: Intensity-modulated radiotherapy. Cancer J 2002, 8:164-175.
13. Nutting C, Dearnaley DP, Webb S: Intensity-modulated radiation therapy: a clinical review. Br J Radiol 2000, 73:459-465.
14. Takahashi S: Conformation radiotherapy: rotation techniques as applied to radiography and radiotherapy of cancer. Acta Radiol Diagn (Stockh) 1965, 242-261.
15. Brahme A: Optimization of stationary and moving beam radiation therapy technique. Radiother Oncol 1988, 12:129-134.
16. Mell LK, Roeske JC, Mundt AJ: Survey of intensity-modulated radiotherapy use in the United States. Cancer 2003, 98:204-211.
17. Zelefsky MJ, Fuks Z, Hunt M, et al.: High-dose intensity-modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002, 53:1111-1118.
18. Eisbruch A, Ship JA, Dawson LA: Salivary gland sparing and improved target irradiation by conformal and intensity-modulated irradiation of head and neck cancer. World J Surg 2003, 27:832-837.
19. Chao KS, Ozyigit G, Tran BN, et al.: Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 2003, 55:312-318.
20. Roeske JC, Lujan A, Rotmensch J, et al.: Intensity-modulated whole pelvis radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000, 48:1613-1621.
21. Selvaraj RN, Gerszten K, King GC, et al.: Conventional 3-D versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative study of dose-volume histograms and the potential impact on toxicities [abstract]. Int J Radiat Oncol Biol Phys 2001, 51:218.
22. Chen Q, Izadifar N, King S, et al.: Comparison of IMRT with 3-D CRT for gynecologic malignancies [abstract]. Int J Radiat Oncol Biol Phys 2001,51:332.
23. Ahamad A, D'Souza W, Salehpour M, et al.: Intensity-modulated radiation therapy (IMRT) for post-hysterectomy pelvic radiation: selection of patients and planning target volume (PTV) [abstract]. Int J Radiat Oncol Biol Phys 2002, 54:42.
24. Lujan AE, Mundt AJ, Yamada D, et al.: Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57:516-521.
25. Portelance L, Chao KS, Grigsby PW, et al.: Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001, 51:261-266.
26. Hong L, Alektiar K, Chui C, et al.: IMRT of large fields: whole abdomen irradiation. Int J Radiat Oncol Biol Phys 2002, 54:278-289.
27. Garofalo M, Lujan AE, Roeske JC, et al.: Intensity-modulated radiation therapy in the treatment of vulvar carcinoma. Paper presented at the 88th Annual Meeting of the Radiologic Society of North America. Chicago, IL, 2002.
28. Gilroy JS, Amdur RJ, Louis DA, et al.: Irradiating the inguinal nodes without breaking a leg [abstract]. Int J Radiat Oncol Biol Phys 2002, 54:68.
29. Mohan R, Wu Q, Manning M, et al.: Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000, 46:619-630.
30. Lujan AE, Mundt AJ, Roeske JC: Sequential versus simultaneous boost in the female pelvis using intensity-modulated radiation therapy. Paper presented at the 43rd Annual Meeting of the American Association of Physicists in Medicine. Salt Lake City, UT 2001.
31. Mutic S, Malyapa RS, Grigsby PW, et al.: PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes: a dose escalation treatment planning study. Int J Radiat Oncol Biol Phys 2003, 55:28-35.
32. Kavanagh B, Schefter TE, Wu Q, et al.: Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002, 12:260-271.
33. Mundt AJ, Roeske JC: Could intensity-modulated radiation therapy (IMRT) replace brachytherapy in the treatment of cervical cancer? Brachyther J 2002, 1:195-196.
34. Alektiar K: Could intensity-modulated radiation therapy (IMRT) replace brachytherapy in the treatment of cervical cancer? Brachyther J 2002, 1:194-195.
35. Roeske JC, Mundt AJ: A feasibility study of IMRT for the treatment of cervical cancer patients unable to receive intracavitary brachytherapy. Med Phys 2000, 27:1382.
36. Low DA, Grigsby PW, Dempsey JF, et al.: Applicator-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2002, 52:1400-1406.
37. Schefter TE, Kavanagh BD, Wu Q, et al.: Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally advanced cervix cancer. Med Dosim 2002, 27:177-184.
38. Mundt AJ, Roeske JC, Lujan AE, et al.: Initial clinical experience with intensity modulated whole pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 2001, 82:456-463.
39. Mundt AJ, Lujan AE, Rotmensch J, et al.: Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 52:1330-1337.
40. Brixey CJ, Roeske JC, Lujan AE, et al.: Impact of intensity-modulated radiation therapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 54:1388-1396.
41. Roeske JC, Bonta D, Lujan AE, et al.: Dose volume histogram analysis of acute gastrointestinal toxicity in gynecologic patients undergoing intensity-modulated whole pelvic radiation therapy. Radiother Oncol 2003, in press.
42. Mundt AJ, Mell LK, Roeske JC: Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56:1354-1360.
43. Mundt AJ, Roeske JC, Lujan JC: IMRT in gynecologic malignancies. Med Dosim 2002, 27:131-136.
44. Adli M, Mayr NA, Kaiser HS, et al.: Does prone positioning reduce bowel dose in pelvic radiation with intensity-modulated radiation therapy (IMRT) for gynecologic cancer. Int J Radiat Oncol Biol Phys 2003, 57:230-238.
45. Hall E, Wuu CS: Radiation-induced second cancer: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003, 56:83-88.